Content area
Abstract
Autism spectrum disorder is a construct used to describe individuals with a specific combination of impairments in social communication and repetitive behaviours, highly restricted interests and/or sensory behaviours beginning early in life. The worldwide prevalence of autism is just under 1%, but estimates are higher in high-income countries. Although gross brain pathology is not characteristic of autism, subtle anatomical and functional differences have been observed in post-mortem, neuroimaging and electrophysiological studies. Initially, it was hoped that accurate measurement of behavioural phenotypes would lead to specific genetic subtypes, but genetic findings have mainly applied to heterogeneous groups that are not specific to autism. Psychosocial interventions in children can improve specific behaviours, such as joint attention, language and social engagement, that may affect further development and could reduce symptom severity. However, further research is necessary to identify the long-term needs of people with autism, and treatments and the mechanisms behind them that could result in improved independence and quality of life over time. Families are often the major source of support for people with autism throughout much of life and need to be considered, along with the perspectives of autistic individuals, in both research and practice.
Autism spectrum disorder — or autism — is a neurodevelopmental disorder that typically manifests in young children. This Primer by Lord and colleagues reviews the epidemiology, mechanisms, clinical detection and treatment of autism.
Details
1 University of California, Los Angeles, Departments of Psychiatry and School of Education, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
2 University of Leicester, Department of Health Sciences, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411)
3 King’s College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
4 Autistica, London, UK (GRID:grid.473765.4)
5 Institut Pasteur, UMR3571 CNRS, Université de Paris, Paris, France (GRID:grid.473765.4)
6 Autism Speaks, New York, USA (GRID:grid.427598.5) (ISNI:0000 0004 4663 7867)
7 University of London, Centre for Brain & Cognitive Development, London, UK (GRID:grid.4464.2) (ISNI:0000 0001 2161 2573)
8 The Sackler Institute for Developmental Psychobiology, New York, USA (GRID:grid.4464.2) ; The Center for Autism and the Developing Brain, White Plains, USA (GRID:grid.4464.2)
9 University of California, Department of Psychiatry, Langley Porter Psychiatric Institute and Weill Institute for Neurosciences, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
10 Vanderbilt University Medical Center, Department of Pediatrics and Vanderbilt Kennedy Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
11 Columbia University, Department of Psychiatry, New York, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)




